{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:21:01Z","timestamp":1785799261689,"version":"3.56.0"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Sepsis is a leading cause of pediatric mortality. Little attention has been paid to the association between viral DNA and mortality in children and adolescents with sepsis.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess the association of the presence of viral DNA with sepsis-related mortality in a large multicenter study.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study compares pediatric patients with and without plasma cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus 1 (HSV-1), human herpesvirus 6 (HHV-6), parvovirus B19 (B19V), BK polyomavirus (BKPyV), human adenovirus (HAdV), and torque teno virus (TTV) DNAemia detected by quantitative real-time polymerase chain reaction or plasma IgG antibodies to CMV, EBV, HSV-1, or HHV-6. A total of 401 patients younger than 18 years with severe sepsis were enrolled from 9 pediatric intensive care units (PICUs) in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Data were collected from 2015 to 2018. Samples were assayed from 2019 to 2022. Data were analyzed from 2022 to 2023.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Death while in the PICU.<\/jats:p><\/jats:sec>Results<\/jats:title>Among the 401 patients included in the analysis, the median age was 6 (IQR, 1-12) years, and 222 (55.4%) were male. One hundred fifty-four patients (38.4%) were previously healthy, 108 (26.9%) were immunocompromised, and 225 (56.1%) had documented infection(s) at enrollment. Forty-four patients (11.0%) died in the PICU. Viral DNAemia with at least 1 virus (excluding TTV) was detected in 191 patients (47.6%) overall, 63 of 108 patients (58.3%) who were immunocompromised, and 128 of 293 (43.7%) who were not immunocompromised at sepsis onset. After adjustment for age, Pediatric Risk of Mortality score, previously healthy status, and immunocompromised status at sepsis onset, CMV (adjusted odds ratio [AOR], 3.01 [95% CI, 1.36-6.45]; P<\/jats:italic>\u2009=\u2009.007), HAdV (AOR, 3.50 [95% CI, 1.46-8.09]; P<\/jats:italic>\u2009=\u2009.006), BKPyV (AOR. 3.02 [95% CI, 1.17-7.34]; P<\/jats:italic>\u2009=\u2009.02), and HHV-6 (AOR, 2.62 [95% CI, 1.31-5.20]; P<\/jats:italic>\u2009=\u2009.007) DNAemia were each associated with increased mortality. Two or more viruses were detected in 78 patients (19.5%), with mortality among 12 of 32 (37.5%) who were immunocompromised and 9 of 46 (19.6%) who were not immunocompromised at sepsis onset. Herpesvirus seropositivity was common (HSV-1, 82 of 246 [33.3%]; CMV, 107 of 254 [42.1%]; EBV, 152 of 251 [60.6%]; HHV-6, 253 if 257 [98.4%]). After additional adjustment for receipt of blood products in the PICU, EBV seropositivity was associated with increased mortality (AOR, 6.10 [95% CI, 1.00-118.61]; P<\/jats:italic>\u2009=\u2009.049).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>The findings of this cohort study suggest that DNAemia for CMV, HAdV, BKPyV, and HHV-6 and EBV seropositivity were independently associated with increased sepsis mortality. Further investigation of the underlying biology of these viral DNA infections in children with sepsis is warranted to determine whether they only reflect mortality risk or contribute to mortality.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.0383","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T16:32:40Z","timestamp":1708965160000},"page":"e240383","source":"Crossref","is-referenced-by-count":15,"title":["Viral DNAemia and DNA Virus Seropositivity and Mortality in Pediatric Sepsis"],"prefix":"10.1001","volume":"7","author":[{"given":"Stephanie S.","family":"Cabler","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Storch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Walton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brengel-Pesce","sequence":"additional","affiliation":[{"name":"bioMerieux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Aldewereld","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell K.","family":"Banks","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Cheynet","sequence":"additional","affiliation":[{"name":"bioMerieux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Reeder","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Holubkov","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pediatrics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wessel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray M.","family":"Pollack","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Meert","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Central Michigan University, Detroit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Newth","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Cornell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick E.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Dean","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Carcillo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"issue":"2","key":"zoi240035r1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/PCC.0000000000002197","article-title":"Executive summary: Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"zoi240035r2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/CCM.0b013e3181d455b6","article-title":"Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study.","volume":"38","author":"Castellanos-Ortega","year":"2010","journal-title":"Crit Care Med"},{"issue":"11","key":"zoi240035r3","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1097\/CCM.0000000000003351","article-title":"The association of nutrition status expressed as body mass index z score with outcomes in children with severe sepsis: a secondary analysis from the Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study.","volume":"46","author":"Irving","year":"2018","journal-title":"Crit Care Med"},{"issue":"1","key":"zoi240035r4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PCC.0000000000000978","article-title":"New or progressive multiple organ dysfunction syndrome in pediatric severe sepsis: a sepsis phenotype with higher morbidity and mortality.","volume":"18","author":"Lin","year":"2017","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"zoi240035r5","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/PCC.0000000000000906","article-title":"Treatment of pediatric septic shock with the surviving sepsis campaign guidelines and PICU patient outcomes.","volume":"17","author":"Workman","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"zoi240035r6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis.","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"zoi240035r7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/infdis\/jiab412","article-title":"Human herpesvirus 6 DNAemia is associated with worse survival after ex vivo T-cell\u2013depleted hematopoietic cell transplant.","volume":"225","author":"Lee","year":"2022","journal-title":"J Infect Dis"},{"issue":"1","key":"zoi240035r8","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/PCC.0000000000001376","article-title":"Viral DNAemia and immune suppression in pediatric sepsis.","volume":"19","author":"Davila","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"zoi240035r9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698808","article-title":"Herpes DNAemia and TTV viraemia in intensive care unit critically ill patients: a single-centre prospective longitudinal study.","volume":"12","author":"Mallet","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"zoi240035r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098819","article-title":"Reactivation of multiple viruses in patients with sepsis.","volume":"9","author":"Walton","year":"2014","journal-title":"PLoS One"},{"key":"zoi240035r11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpeds.2019.06.033","article-title":"DNA viremia is associated with hyperferritinemia in pediatric sepsis.","volume":"213","author":"Simon","year":"2019","journal-title":"J Pediatr"},{"key":"zoi240035r12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcrc.2021.08.015","article-title":"Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome.","volume":"66","author":"Gonzalez","year":"2021","journal-title":"J Crit Care"},{"issue":"4","key":"zoi240035r13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.300.4.413","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients.","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"issue":"8","key":"zoi240035r14","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/CCM.0b013e3181a3aa43","article-title":"Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit.","volume":"37","author":"Kalil","year":"2009","journal-title":"Crit Care Med"},{"issue":"3","key":"zoi240035r15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jcv.2007.11.014","article-title":"Human cytomegalovirus: latency and reactivation in the myeloid lineage.","volume":"41","author":"Sinclair","year":"2008","journal-title":"J Clin Virol"},{"issue":"7","key":"zoi240035r16","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/01.CCM.0000070222.11325.C4","article-title":"Occult herpes family viral infections are endemic in critically ill surgical patients.","volume":"31","author":"Cook","year":"2003","journal-title":"Crit Care Med"},{"issue":"9","key":"zoi240035r17","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/08850666211053990","article-title":"Reactivation of EBV and CMV in severe COVID-19\u2013epiphenomena or trigger of hyperinflammation in need of treatment? a large case series of critically ill patients.","volume":"37","author":"Naendrup","year":"2022","journal-title":"J Intensive Care Med"},{"key":"zoi240035r18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases.","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"zoi240035r19","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1002\/jmv.v94.11","article-title":"SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era?","volume":"94","author":"Chen","year":"2022","journal-title":"J Med Virol"},{"issue":"6578","key":"zoi240035r20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"7","key":"zoi240035r21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005025","article-title":"Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): a meta-analysis of prospective studies up to 2016.","volume":"6","author":"Wang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"zoi240035r22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1030440","article-title":"Persistent viral infections and their role in heart disease.","volume":"13","author":"Badrinath","year":"2022","journal-title":"Front Microbiol"},{"issue":"7142","key":"zoi240035r23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature05762","article-title":"Herpesvirus latency confers symbiotic protection from bacterial infection.","volume":"447","author":"Barton","year":"2007","journal-title":"Nature"},{"issue":"2","key":"zoi240035r24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.virol.2008.07.031","article-title":"Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis.","volume":"380","author":"Nguyen","year":"2008","journal-title":"Virology"},{"issue":"12","key":"zoi240035r25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure.","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"zoi240035r26","first-page":"333","article-title":"Validity of the updated Pediatric Risk of Mortality Score (PRISM III) in predicting the probability of mortality in a pediatric intensive care unit.","volume":"42","author":"Wang","year":"2001","journal-title":"Acta Paediatr Taiwan"},{"issue":"5","key":"zoi240035r27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: an updated Pediatric Risk of Mortality score.","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"key":"zoi240035r28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa697","article-title":"Risk Factors for Cytomegalovirus Reactivation and Association with Outcomes in Critically Ill Adults with Sepsis: A Pooled Analysis of Prospective Studies.","author":"Imlay","journal-title":"J Infect Dis"},{"issue":"1","key":"zoi240035r29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s13054-021-03843-8","article-title":"HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.","volume":"25","author":"Meyer","year":"2021","journal-title":"Crit Care"},{"issue":"6","key":"zoi240035r30","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/S0002-9440(10)63575-4","article-title":"Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response.","volume":"163","author":"Theil","year":"2003","journal-title":"Am J Pathol"},{"issue":"6","key":"zoi240035r31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19.","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi240035r32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ejim.2006.05.002","article-title":"Parvovirus B19 reactivation presenting as neutropenia after rituximab treatment.","volume":"17","author":"Klepfish","year":"2006","journal-title":"Eur J Intern Med"},{"issue":"9","key":"zoi240035r33","article-title":"Parvovirus reactivation in COVID-19.","volume":"13","author":"Lai","year":"2021","journal-title":"Cureus"},{"issue":"9","key":"zoi240035r34","doi-asserted-by":"publisher","DOI":"10.12890\/2020_001596","article-title":"Severe refractory anaemia and fever of unknow origin: human parvovirus B19 reactivation.","volume":"7","author":"Escobar-Sevilla","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"issue":"11","key":"zoi240035r35","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/v12111292","article-title":"Torque teno virus viral load as a marker of immune function in allogeneic haematopoietic stem cell transplantation recipients.","volume":"12","author":"Mouton","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"zoi240035r36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.trre.2019.03.004","article-title":"Torque-teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation.","volume":"33","author":"Rezahosseini","year":"2019","journal-title":"Transplant Rev (Orlando)"},{"issue":"8","key":"zoi240035r37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/jama.2017.10569","article-title":"Effect of ganciclovir on IL-6 levels among cytomegalovirus-seropositive adults with critical illness: a randomized clinical trial.","volume":"318","author":"Limaye","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"zoi240035r38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13613-020-00793-2","article-title":"Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation.","volume":"11","author":"Papazian","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"5","key":"zoi240035r39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in US children ages 6-19, 2003-2010.","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"zoi240035r40","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv193","article-title":"Cytomegalovirus seroprevalence among children and adolescents in Germany: data from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003-2006.","volume":"3","author":"Voigt","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"zoi240035r41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJM199408183310703","article-title":"Human herpesvirus-6 infection in children: a prospective study of complications and reactivation.","volume":"331","author":"Hall","year":"1994","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi240035r42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi240035r43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcv.2008.07.012","article-title":"Cytomegalovirus seroprevalence and childhood sources of infection: a population-based study among pre-adolescents in the United States.","volume":"43","author":"Staras","year":"2008","journal-title":"J Clin Virol"},{"issue":"4","key":"zoi240035r44","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jpeds.2007.04.065","article-title":"Seroprevalence of herpes simplex virus type 1 in children in the United States.","volume":"151","author":"Xu","year":"2007","journal-title":"J Pediatr"},{"issue":"8","key":"zoi240035r45","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.","volume":"296","author":"Xu","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"zoi240035r46","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.v29.3","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis.","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"issue":"2","key":"zoi240035r47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00000542-199602000-00005","article-title":"Cytomegalovirus: an unexpected cause of ventilator-associated pneumonia.","volume":"84","author":"Papazian","year":"1996","journal-title":"Anesthesiology"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2815462\/cabler_2024_oi_240035_1711560384.47024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T18:01:37Z","timestamp":1711562497000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2815462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.0383","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]}}}